目的 探討腎移植患者非結核分枝桿菌(NTM)病臨床特點及分子診斷。 方法 回顧性分析2011年4月1例皮膚軟組織NTM感染的腎移植患者的臨床特點,并以其病變組織DNA為模板,聚合酶鏈反應(PCR)擴增hsp65基因和rpoB基因序列,測序比對鑒定其NTM菌種。結合文獻復習NTM病及分析分子生物學技術在移植患者NTM感染診斷中的作用。 結果 該腎移植患者系皮膚軟組織胞內分枝桿菌感染,臨床特點與結核病極其相似,難以進行鑒別診斷。PCR擴增、測序的結果顯示hsp65產物和rpoB產物序列與胞內分枝桿菌GeneBank中FJ643456.1及CP003324.1序列100%一致。 結論 NTM病的臨床表現與結核病相似,分子生物學方法鑒定菌種對移植患者胞內分枝桿菌病的診斷有幫助。
ObjectiveTo explore the value of active surveillance (AS) with ultrasound for papillary thyroid microcarcinoma (PTMC) tumor growth.MethodsA retrospective collection of 196 patients who underwent ultrasound-guided fine-needle aspiration biopsy at West China Hospital of Sichuan University from January 2014 to December 2018 were pathologically diagnosed as PTMC, and no cervical lymph node metastasis was found on ultrasound, and AS was performed. According to the change of the maximum diameter of the nodule, the patients were divided into the maximum diameter increase group, the maximum diameter stable group and the maximum diameter reduction group. According to the nodule volume change, the patients were divided into the volume increase group, the volume stable group and the volume reduction group. The differences in the patients’ gender, age, with Hashimoto’s thyroiditis, follow-up time, tumor size, boundary, shape, echo, aspect ratio, calcifications, multifocality, bilateral involvement, other nodule, surrounding tissues and cervical lymph nodes among the different groups were analyzed in order to clarify the related factors of tumor growth.ResultsOne hundred and ninety-six patients had ultrasound AS time ranging from 6 to 79 months with the median (quartile) time were 16.0 (10.0, 30.0) months. One hundred and seventeen patients (59.7%) were in AS for 6 to 63 months with the median (quartile) time were 13.0. (8.0, 22.0), surgical treatments were performed after termination of AS. Forty-five patients (23.0%) continued to perform AS, 34 patients (17.3%) did not continue to perform AS in West China Hospital of Sichuan University. There was no significant reduction in the maximum diameter and volume of the nodules in all cases. Among them, 9 cases (4.6%) had an increase in the maximum diameter of the nodules, and 187 cases (95.4%) had a stable maximum diameter. Forty cases (20.4%) had an increase in the volume of the nodules, and 156 cases (79.6%) had a stable volume of the nodules. Comparison of the maximum diameter change of nodules between the two groups, there was a significant difference in the age of patients (P<0.05). Comparison of the maximum volume change between the two groups, there were significant differences in age, follow-up time and initial nodule volume (P<0.05). Logistic regression analysis showed that younger age was an independent risk factor for PTMC nodule growth [OR=0.638, 95%CI (0.601, 0.675), P=0.015].ConclusionsYounger age is a risk factor for PTMC tumor growth. We should adopt a more active monitoring program for younger patients. The increase of PTMC tumor volume can be more easily monitored than the increase of its maximum diameter, so it can be used as an indicator to predict nodule growth at an earlier stage in AS.
Objective To explore the manifestations and features of multi-slice spiral CT (MSCT) in the diagnosisof papillary thyroid carcinoma (PTC). Methods Preoperative MSCT data of 35 cases of PTC proved by operation and pathology in our hospital form May. to Jun. in 2013 were observed retrospectively, to analyze the manifestations and characteristics of MSCT for it. Results Of 35 patients with PTC, MSCT totally showed 48 lesions, 68.6% (24/35) of patients with single lesion, 31.4% (11/35) of patients with 2-3 lesions, and 62.9% (22/35) of patients with lymph node metastasis. Of the 48 lesions, 29.2% (14/48) of lesions located in the left lobe, 70.8% (34/48) of lesions located in the right lobe;the lesions’ maximum diameter were 0.4-5.8cm, with the average maximum diameter of 1.3cm. There were 39.6% (19/48) of lesions with uneven density, 25.0% (12/48) of lesions with irregular shape, 47.9% (23/48) of lesions with blurred edges, 18.8% (9/48) of lesions had papillary enhanced tumor nodules, 10.4% (5/48) of lesions had peritumoral incomplete enhanced ring sign, 22.9% (11/48) of lesions invaded surrounding tissue or organs. There were 35.4% (17/48) of lesions had calcification, in which 76.4% (13/17) of lesions were fine granular calcification, 11.8% (2/17) of lesions were mixed calcification, and 11.8% (2/17) of lesions were coarse calcification. Conclusion MSCT manifestations of PTC have certain characteristics, which can provide imaging basis for clinical treatment options.
Objective To explore the risk factors the central cervical lymph node micrometastasis of papillary thyroid microcarcinoma (PTMC). Methods PTMC patients who underwent surgical operations in West China Hospital, Sichuan University between January 2014 and December 2018 were retrospectively enrolled. The patient did not find lymph node metastasis in the central cervical area by preoperative ultrasound. During the operation, the central cervical lymph node of the affected side was dissected or lymph node dissection in the central area of the affected side of the neck plus the lateral area of the neck. With postoperative pathology as the gold standard, patients were divided into central cervical lymph node micrometastasis group (micrometastasis group) and central cervical lymph node non-metastasis group (non-metastasis group). The differences of clinical features and ultrasonic signs between the two groups were analyzed. Results A total of 507 patients were included, including 223 (44.0%) in the micrometastasis group and 284(56.0%) in the non-metastasis group. The results of univariate analysis showed that compared with the non-metastasis group, the patients in the micrometastasis group were younger, the tumor size were higher, the proportion of male, multifocality, bilateral involvement and thyroid capsular invasion were higher. The results of multiple logistic regression analysis showed that lower age [odds radio (OR)=0.967, 95% confidence interval (CI)(0.949, 0.985), P<0.001], male [OR=2.357, 95%CI (1.503, 3.694), P<0.001)], a larger maximum diameter of PTMC [OR=1.232, 95%CI (1.100, 1.379), P<0.001], a larger nodule volume of PTMC [OR=1.031, 95%CI (1.008, 1.114), P=0.032], multifocal lesion [OR=2.309, 95%CI (1.167, 4.570), P=0.016] and invasion of the thyroid capsule [OR=1.520, 95%CI (1.010, 2.286), P=0.045] were independent risk factors for central cervical lymph node micrometastasis. Conclusions The patient’s male, young age, PTMC nodule with large maximum diameter and large volume, multifocal, and invasion of the thyroid membrane are risk factors for the central cervical lymph node micrometastasis of PMTC patients. These clinical and ultrasound signs can provide a theoretical basis for doctors’ clinical management decisions.
目的 探討胃癌組織中人表皮生長因子受體(EGFR)、表皮生長因子受體-2(HER-2)和環氧合酶-2(COX-2)的表達及與臨床病理特征的關系。 方法 應用免疫組織化學Envision二步法,檢測70例胃癌組織中EGFR、HER-2和COX-2的表達情況,并結合其臨床病理特點進行分析。 結果 EGFR、HER-2和COX-2在胃癌組織中的表達陽性率分別為35.7%(25/70)、27.1%(19/70)、67.1%(47/70)。陽性表達與腫瘤分化程度、侵襲深度、有無淋巴結轉移及TNM分期有關(P<0.05),而與患者的性別及年齡、腫瘤部位和大小無關(Pgt;0.05)。EGFR、HER-2和COX-2三者之間在胃癌組織中的表達均呈正相關(P<0.05)。 結論 EGFR、HER-2和COX-2的表達參與胃癌的生長、侵襲和轉移過程。它們的聯合檢測有助于胃癌患者靶向藥物的選擇,也為胃癌的預后判斷提供客觀的參考指標。Objective To observe the expressions of epidermal growth factor receptor (EGFR), HER-2 and cyclooxygenase-2 (COX-2) in gastric carcinoma (GC) and to explore the relationship among them. Methods The envision immunohistochemical stain method was used to detect EGFR, HER-2 and COX-2 protein expressions in sample of 70 GC tissues. And their corresponding pathologic features were analyzed. Results The positive expression rates of EGFR, HER-2 and COX-2 protein in GC tissue were 35.7% (25/70), 27.1% (19/70) and 67.1% (47/70), respectively. The positive expression rates were closely relevant to the differentiation of the cancer, invasion depth, lymphatic metastasis and TNM (P<0.05), but not to the patient’ s sex, age, tumor site and size (P>0. 05). There was a stable positive correlation among EGFR, HER-2 and COX-2 expressions in GC tissues, respectively. Conclusions EGFR, HER-2 and COX-2 expressions participate in the development, invasion and metastasis process of GC. Combined detection can be regarded as an important symbol for guiding the molecular targeting therapy of GC, and judging the prognosis of GC.
ObjectiveTo investigate the relationship between the expression of programmed cell death ligand-1 (PD-L1) and the maximal standardized uptake value (SUVmax) in 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) and the correlation of clinical factors between SUVmax values and PD-L1.MethodsThe clinical data of 84 patients with invasive lung adenocarcinoma diagnosed pathologically in West China Hospital, Sichuan University from August 2016 to November 2018 were analyzed retrospectively, including 38 males and 46 females, aged 60 (32-85) years. The tumor was acinar-predominant in 37 patients, papillary in 20, lepidic in 19, solid in 5 and micropapillary in 3. Multivariate analysis of the relationship between SUVmax value and other clinicopathological features was performed by linear regression. Logistic regression analysis was used to analyze the relationship between PD-L1 protein expression and other pathological features.ResultsThe SUVmax of the PD-L1 expression group was significantly higher than that of the non-PD-L1 expression group in the whole invasive lung adenocarcinoma group (P=0.002) and intermediate-grade histologic subtype (P=0.016). The SUVmax cut-off value of PD-L1 expression in the whole invasive lung adenocarcinoma group and intermediate-grade histologic subtype was 5.34 (AUC: 0.732, P=0.002) and 5.34 (AUC: 0.720, P=0.017), respectively. Multivariate analysis showed that pleura involvement, vascular tumor thrombus and the increase of tumor diameter could cause the increase of the SUVmax value, while the SUVmax value decreased in the moderately differentiated tumor compared with the poorly differentiated tumor. The SUVmax cut-off value between low-grade histologic subtype and intermediate-grade histologic subtype, intermediate-grade histologic subtype and high-grade histologic subtypes was 1.54 (AUC: 0.854, P<0.001) and 5.79 (AUC: 0.889, P<0.001), respectively. Multivariate analysis of PD-L1 expression showed pleura involvement (P=0.021, OR=0.022, 95%CI 0.001 to 0.558) and moderate differentiation (opposite to poor differentiation) (P=0.004, OR=0.053, 95%CI 0.007 to 0.042) decreased the expression of PD-L1.ConclusionThe SUVmax of the PD-L1 expression group is significantly higher than that of the non-PD-L1 expression group in the whole invasive lung adenocarcinoma group and intermediate-grade histologic subtype. The level of SUVmax and the expression of PD-L1 in invasive lung adenocarcinoma are related to many clinical factors.
Objective To construct AWP1 (associated with protein kinase C related kinase 1) recombinant adenovirus as the tool of transferring the gene and investigate its expression and localization in human vascular endothelial cell ECV304. Methods Cloned AWP1 cDNA was inserted into the multiply clone sites (MCS) of plasmid pcDNA3 for adding flag tag, and the flag-AWP1 gene was subcloned into shuttle vector pAdTrack-CMV. After identified with restrictional enzymes, plasmid pAdTrack-flag-AWP1 was linearized by digestion with restriction endonuclease PmeⅠ, and subsequently cotransformed into E.coli BJ5183 cells with adenoviral backbone plasmid pAdEasy-1 to make homologous recombination. After linearized by PacⅠ, the homologous recombinant adenovirus plasmid transfected into 293 cells with Lipofectamine to pack recombinant adenovirus. After PCR assay of recombinant adenovirus granules, recombinant adenoviruses infected 293 cells repeatedly for obtaining the high-level adenoviruses solution. And then, the recombinant adenoviruses infected human ECV304 cells for observing the expression and localization of AWP1 under laser scanning confocal microscope (LSCM). Results PCR assay showed that recombinant adenovirus Ad-flag-AWP1 was obtained successfully; and ECV304 cells were infected high-efficiently by the homologous recombinant virus. Then, it was observed that flag-AWP1 protein expressed in ECV304 cells and distributed in the leading edges of the cell membrane. Conclusion The vectors of flag-AWP1 recombinant adenovirus are constructed, and the localization of AWP1 protein in ECV304 cells might show that AWP1 may be a potential role on the cell signal transduction.
The Department of Thoracic Surgery of Shanghai Chest Hospital has performed esophageal function testing for over 30 years, being the only department of its kind in China with this capability. The pressure testing and 24-hour pH/impedance monitoring of the esophagus is of great help to assist in the diagnosis and treatment of benign and malignant esophageal diseases related to it. Thanks to the esophageal function test, in addition to the routine various endoscopic anti-reflux procedures, our hospital has taken the lead in China in recent years to carry out a series of clinical and research work for benign esophageal diseases, such as the development of magnetic ring, double nedoscopic combination and new anti-reflux endoscopic techniques. In recent years, we have carried out high-resolution esophageal manometry and 24-hour pH/impedance monitoring for patients with interstitial pneumonia and pulmonary fibrosis suspected to be caused by gastroesophageal acid reflux. We can better assess the correlation between gastroesophageal reflux and pulmonary fibrosis, and to provide the different clinical treatments and even surgical interventions. The Bravo capsule is used more often in the United States, and it has obvious advantages over traditional approach for acid measurement. We strongly call for the collaboration between industry and academic institutions in this field, and the development of our own related products with independent intellectual property rights.
目的 通過對保留不同平面骶骨的新鮮人骨盆模型進行生物力學測試,分析骶骨切除平面與骨盆穩定性的關系,明確骶骨切除保留至何種程度時需行腰骶髂穩定性重建。 方法 選用6具正常成年男性新鮮尸體腰5-骨盆標本,采用200 N增量分級加載,以1.4 mm/min速率平穩加載直至1 000 N,依次測試保留完整骶骨及不同平面骶骨切除骨盆模型的最大主應力、剪切應力、位移及剛度變化,比較各組間的差異。最后測量1/2S1組骨盆環的極限載荷,記錄骨折發生部位和骨折類型。 結果 隨骶骨切除平面增高,最大主應力、剪切力及骶骨下沉位移在各測試點均有不同程度增大,骨盆的軸向剛度不斷減小。當切除平面達骶1時,變化明顯,尤其以經過骶1下1/4~下1/2時變化顯著,與完整骶骨組比較,差異有統計學意義(P<0.05)。骶1椎體下1/2平面切除后,骨盆的極限載荷是(2 375.97 ± 162.41)N,骨盆的破壞形態為經骶髂關節或骶椎的骨折。 結論 骶骨切除范圍與骨盆環的穩定性密切相關,隨著骶骨切除平面升高,殘留骶髂關節各種應力急劇增高,骨盆的穩定性明顯下降。當骶骨切除涉及骶1椎體時,極易發生骨折,需要進行腰骶髂局部重建以增強骶髂關節的穩定性。